Target Name: NACA4P
NCBI ID: G83955
Review Report on NACA4P Target / Biomarker Content of Review Report on NACA4P Target / Biomarker
NACA4P
Other Name(s): NACAP1 | FKSG17 | NACA family member 4, pseudogene

NACA4P: A Protein Involved in TOR Pathway and Cellular Processes Essential for Cell Survival and Growth

NACA4P, or N-Acetyl-L-Cysteine (NAC)yl-L-Argine (L-Arg), is a protein that is expressed in various tissues throughout the body. It is a key player in the intracellular signaling pathway known as the TOR (Temporal Organization) pathway. This pathway is responsible for regulating various cellular processes that are essential for cell survival and growth, including cell growth, differentiation, metabolism, and stress resistance.

The NACA4P protein has been identified as a potential drug target or biomarker due to its unique structure and its involvement in multiple cellular processes. It is a 21-kDa protein that consists of a N-acetylated lysine residue, a cysteine residue, and an Argine residue. The N-acetyl group is a common modification that has been observed in various proteins, including some proteins involved in signaling pathways. The cysteine residue is a modified form of the amino acid cysteine, which has been shown to have various functions in cellular signaling. The Argine residue is a modified form of the amino acid arginine, which is involved in various cellular processes, including cell signaling, inflammation, and stress resistance.

The NACA4P protein has been shown to play a critical role in the TOR pathway. The TOR pathway is a complex signaling pathway that is involved in the regulation of various cellular processes, including cell growth, differentiation, metabolism, and stress resistance. The NACA4P protein is a key player in this pathway, as it has been shown to be involved in the regulation of several TOR pathway-related processes, including the positive regulation of TOR activity and the negative regulation of several TOR pathway-related genes.

One of the most significant functions of the NACA4P protein is its role in the regulation of the TOR pathway. The TOR pathway is a complex signaling pathway that is involved in the regulation of various cellular processes, including cell growth, differentiation, metabolism, and stress resistance. The NACA4P protein is a key player in this pathway, as it has been shown to be involved in the regulation of several TOR pathway-related processes, including the positive regulation of TOR activity and the negative regulation of several TOR pathway-related genes.

The NACA4P protein has been shown to play a critical role in the regulation of cellular processes that are essential for cell survival and growth. For example, studies have shown that the NACA4P protein is involved in the regulation of cell growth, cell cycle progression, and apoptosis. NACA4P has also been shown to play a critical role in the regulation of cell metabolism, as it has been shown to be involved in the regulation of various cellular metabolism-related processes, including the regulation of energy metabolism and the regulation of amino acid metabolism.

In addition to its role in the TOR pathway, the NACA4P protein has also been shown to play a critical role in the regulation of cellular processes that are essential for cell survival and growth. For example, studies have shown that the NACA4P protein is involved in the regulation of cell growth, cell cycle progression, and apoptosis. NACA4P has also been shown to play a critical role in the regulation of cell metabolism, as it has been shown to be involved in the regulation of various cellular metabolism-related processes, including the regulation of energy metabolism and the regulation of amino acid metabolism.

The NACA4P protein is also involved in the regulation of various cellular signaling pathways that are essential for

Protein Name: NACA Family Member 4, Pseudogene

The "NACA4P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NACA4P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NACAD | NACC1 | NACC2 | NAD(P)H dehydrogenase, quinone | NAD-Dependent Protein Deacetylase | NADH dehydrogenase (Complex I) | NADK | NADK2 | NADPH Oxidase | NADPH Oxidase Complex | NADSYN1 | NAE1 | NAF1 | NAG18 | NAGA | NAGK | NAGLU | NAGPA | NAGPA-AS1 | NAGS | NAIF1 | NAIP | NAIPP2 | NALCN | NALCN sodium channel complex | NALCN-AS1 | NALF1 | NALF2 | NALT1 | NAMA | NAMPT | NAMPTP1 | NANOG | NANOGNB | NANOGP1 | NANOGP8 | NANOS1 | NANOS2 | NANOS3 | NANP | NANS | NAP1L1 | NAP1L1P1 | NAP1L2 | NAP1L3 | NAP1L4 | NAP1L4P1 | NAP1L5 | NAP1L6P | NAPA | NAPA-AS1 | NAPB | NAPEPLD | NAPG | NAPRT | NAPSA | NAPSB | NARF | NARS1 | NARS2 | Nascent polypeptide-associated complex | NASP | NAT1 | NAT10 | NAT14 | NAT16 | NAT2 | NAT8 | NAT8B | NAT8L | NAT9 | NATD1 | Natural cytotoxicity triggering Receptor | NAV1 | NAV2 | NAV2-AS5 | NAV2-AS6 | NAV3 | NAXD | NAXE | nBAF complex | NBAS | NBAT1 | NBDY | NBEA | NBEAL1 | NBEAL2 | NBEAP1 | NBEAP3 | NBL1 | NBN | NBPF1 | NBPF10 | NBPF11 | NBPF12 | NBPF14 | NBPF15 | NBPF17P | NBPF18P | NBPF19